Coronavirus (SARS-CoV) Recruiting Phase 3 Trials for Hydroxychloroquine (DB01611)

Back to Coronavirus (SARS-CoV)

Also known as: Severe Acute Respiratory Syndrome / SARS-CoV Infection / SARS Virus / SARS / Sar / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

Indication	Status	Phase
DBCOND0038241 (Coronavirus (SARS-CoV))	Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04403100	Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"	Treatment	Hydroxychloroquine (DB01611) Lopinavir (DB01601) Ritonavir (DB00503)